HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MaryAnn Go Selected Research

3'- deamino- 3'',4'- anhydro- (2''- methoxy- 3''- oxy- 4''- morpholinyl)doxorubicin

7/2015A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


MaryAnn Go Research Topics

Disease

4Neoplasms (Cancer)
01/2021 - 07/2013
1Neoplasm Metastasis (Metastasis)
01/2021
1Hodgkin Disease (Hodgkin's Disease)
01/2021
1Prostatic Neoplasms (Prostate Cancer)
05/2016
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2013
1Lymphoma (Lymphomas)
07/2013

Drug/Important Bio-Agent (IBA)

3Immunoconjugates (Immunoconjugate)IBA
01/2021 - 07/2013
2Pharmaceutical PreparationsIBA
01/2021 - 07/2013
2monomethyl auristatin EIBA
01/2021 - 05/2016
2auristatinIBA
01/2021 - 07/2013
2pinatuzumab vedotinIBA
07/2015 - 07/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2021
1Brentuximab VedotinIBA
01/2021
13'- deamino- 3'',4'- anhydro- (2''- methoxy- 3''- oxy- 4''- morpholinyl)doxorubicinIBA
07/2015
1AnthracyclinesIBA
07/2015
1AntigensIBA
07/2013
1Rituximab (Mabthera)FDA Link
07/2013

Therapy/Procedure

1Castration
05/2016
1Combination Drug Therapy (Combination Chemotherapy)
07/2013